IDEAS home Printed from https://ideas.repec.org/a/epw/ejbio0/v3y2022i2id17332.html

CRISPR-Cas Technology, the Tool of the Future

Author

Listed:
  • Alejandro Esquivel Álvarez

    (University of Costa Rica, Costa Rica)

  • Elías Quesada Morales

    (University of Costa Rica, Costa Rica)

  • María Paz Villegas Calero

    (University of Costa Rica, Costa Rica)

  • Daniela Matarrita Brenes

    (Universidad de Costa Rica, Costa Rica)

  • María Fernanda Rojas Salas

    (University of Costa Rica, Costa Rica)

  • German Madrigal Redondo

    (University of Costa Rica, Costa Rica)

  • Marianela Chavarría Rojas

    (University of Costa Rica, Costa Rica)

  • Eleaneth Baltodano Viales

    (University of Costa Rica, Costa Rica)

Abstract

The CRISPR-Cas system discovered in the eighties consists of a series of RNA proteins that signal and messengers of the immune system in prokaryotic organisms to protect against invading antigens of various sources. After the CRISPR-Cas discovery, many research advances were made in the following decades regarding knowledge, techniques, and applications. This showed the system could edit the DNA in an exact and specific manner, which made it very promising to exploit it in various fields, such as the therapeutic field. New therapies of various diseases, industrial applications, food manufacturing, among others, make its impact quite relevant. The following review will focus on the fundamental understanding and implications of CRISPR-Cas techniques has with an ethical and legal view. In addition, to explore some of the applications present and future in the healthcare department, some methods of drug delivery in gene therapy, and new research that is being developed with the CRISPR-Cas technology.

Suggested Citation

Handle: RePEc:epw:ejbio0:v:3:y:2022:i:2:id:17332
DOI: 10.24018/ejbio.2022.3.2.332
as

Download full text from publisher

File URL: https://eu-opensci.org/index.php/ejbio/article/view/17332
File Function: Abstract page
Download Restriction: no
File URL: https://eu-opensci.org/index.php/ejbio/article/download/17332/4247
File Function: Full text
Download Restriction: no
File URL: https://libkey.io/10.24018/ejbio.2022.3.2.332?utm_source=ideas
LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
---><---

More about this item

Keywords

;
;
;
;
;
;

Statistics

Access and download statistics

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejbio0:v:3:y:2022:i:2:id:17332. See general information about how to correct material in RePEc.

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

We have no bibliographic references for this item. You can help adding them by using this form .

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejbio .

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.